ChemFeeds Site Navigation:
Journal Selection:
Search:

99) Dose-Response in Phase I Trials (Clinical Cancer Research) Thursday November 13th 2014


100) Phase I Trial of Bortezomib and Bolus-Infusion Alvocidib (Clinical Cancer Research) Thursday November 13th 2014


101) Perifosine and Sorafenib in Lymphoproliferative Diseases (Clinical Cancer Research) Thursday November 13th 2014


102) Pediatric Brain Tumors--Molecular Subtypes (Clinical Cancer Research) Thursday November 13th 2014


103) Brain Tumor Immunotherapy (Clinical Cancer Research) Thursday November 13th 2014


104) Angiogenesis Inhibition in Glioblastoma (Clinical Cancer Research) Thursday November 13th 2014


105) Molecular Markers in Diffuse Glioma (Clinical Cancer Research) Thursday November 13th 2014


106) Brain Tumor Clinical Research (Clinical Cancer Research) Thursday November 13th 2014


107) Central Nervous System Malignancies: What Next? (Clinical Cancer Research) Thursday November 13th 2014


108) Targeting IL6/IL11 Signaling in Solid Cancers (Clinical Cancer Research) Thursday November 13th 2014


109) Resistance to Next-Generation ALK Inhibitors in Lung Cancer (Clinical Cancer Research) Thursday November 13th 2014


110) Cancer Immunotherapy Using Polyclonal Gamma Delta T Cells (Clinical Cancer Research) Thursday November 13th 2014


111) Galectin-1 and Radiation-Related Lymphopenia (Clinical Cancer Research) Friday October 31st 2014


112) Androstenedione Is the Preferred Androgen Source in Human HRPC (Clinical Cancer Research) Friday October 31st 2014


113) PI3K Pathway, a Therapeutic Target in Melanoma Brain Mets (Clinical Cancer Research) Friday October 31st 2014


114) PTEN Loss in Stage IIIB/C Melanoma (Clinical Cancer Research) Friday October 31st 2014


115) Activating FGFR2-RAS-BRAF Mutations in Ameloblastoma (Clinical Cancer Research) Friday October 31st 2014


116) Cutaneous Antimicrobial Defense and Th17-Cell Function in CTCL (Clinical Cancer Research) Friday October 31st 2014


117) Preclinical Activity of Lipoplatin in Ovarian Cancer (Clinical Cancer Research) Friday October 31st 2014


118) IGF1R: A Novel Target for Mutant RAS-Positive Cancer (Clinical Cancer Research) Friday October 31st 2014


119) RB Loss Alters Therapeutic Response (Clinical Cancer Research) Friday October 31st 2014


120) Vaccination to Generate Resident T Cells in Genital Tract (Clinical Cancer Research) Friday October 31st 2014


121) NANOGP8 Inhibition Enhances BH3 Mimetic Efficacy (Clinical Cancer Research) Friday October 31st 2014


122) dCK and Response to Gemcitabine in Bladder Cancer (Clinical Cancer Research) Friday October 31st 2014


123) Targeting MUC1-C Inhibits Mutant EGFR Signaling (Clinical Cancer Research) Friday October 31st 2014


124) mTOR Inhibitors Inhibit Tumor Growth in EBV T/NK Lymphoma (Clinical Cancer Research) Friday October 31st 2014


125) Mapping Tumor Oxygenation Using MRI (Clinical Cancer Research) Friday October 31st 2014


126) Belinostat plus Chemotherapy for Thymic Epithelial Tumors (Clinical Cancer Research) Friday October 31st 2014


127) Cisplatin-Induced Immunomodulation (Clinical Cancer Research) Friday October 31st 2014


128) Intercellular PTEN (Clinical Cancer Research) Friday October 31st 2014


129) Epigenetic Modulation of Wnt-GSK3 Signaling (Clinical Cancer Research) Friday October 31st 2014


130) Ibrutinib for MCL (Clinical Cancer Research) Friday October 31st 2014


131) Pertuzumab Neoadjuvant Approval Summary (Clinical Cancer Research) Friday October 31st 2014


132) Developmental Therapeutics in Cervical Cancer (Clinical Cancer Research) Friday October 31st 2014


133) Melanoma Brain Metastases (Clinical Cancer Research) Friday October 31st 2014


134) Androstenedione Function in Androgen Production (Clinical Cancer Research) Friday October 31st 2014


135) Correction: Targeting miR21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth (Clinical Cancer Research) Wednesday October 15th 2014


136) Smoking and Risk of Prostate Cancer (Clinical Cancer Research) Wednesday October 15th 2014


137) dMMR and BRAF in Metastatic Colorectal Cancer Patients (Clinical Cancer Research) Wednesday October 15th 2014


138) Integrated Epigenetic Regulation in Bladder Cancer (Clinical Cancer Research) Wednesday October 15th 2014


139) Overdetection of Recurrence after Radical Prostatectomy (Clinical Cancer Research) Wednesday October 15th 2014


140) IDO, CTLA-4, PD-L1 Synergistic Blockade in Brain Tumors (Clinical Cancer Research) Wednesday October 15th 2014


141) Pharmacogenomic Modeling in Pancreatic Cancer (Clinical Cancer Research) Wednesday October 15th 2014


142) Gene Profile Predictive of Postmastectomy Radiotherapy (Clinical Cancer Research) Wednesday October 15th 2014


143) Gene Signature-Guided Dasatinib Therapy in Breast Cancer (Clinical Cancer Research) Wednesday October 15th 2014


144) A Phase I Study of CPI-613 (Clinical Cancer Research) Wednesday October 15th 2014


145) Changing the Landscape of PTCL Care (Clinical Cancer Research) Wednesday October 15th 2014


146) Chemotherapy-Free Approaches in Indolent Lymphoma (Clinical Cancer Research) Wednesday October 15th 2014


147) Clinical Research on HTLV-1-Associated ATL (Clinical Cancer Research) Wednesday October 15th 2014


148) Infections and Marginal Zone Lymphomas (Clinical Cancer Research) Wednesday October 15th 2014


149) Ki-67 and Tailored Therapy in MCL (Clinical Cancer Research) Wednesday October 15th 2014


150) Precision Treatment of DLBCL (Clinical Cancer Research) Wednesday October 15th 2014


151) Putting the Heterogeneity of NHL in Context (Clinical Cancer Research) Wednesday October 15th 2014


152) The Lymphoma Medicine Cabinet (Clinical Cancer Research) Wednesday October 15th 2014


153) Myeloid Complicity in Cancer (Clinical Cancer Research) Wednesday October 15th 2014


154) New Strategies in Ovarian Cancer (Clinical Cancer Research) Wednesday October 15th 2014


155) Blocking Immune Suppression in Glioma (Clinical Cancer Research) Wednesday October 15th 2014


156) Correction: A Severe Combined Immunodeficient-hu In Vivo Mouse Model of Human Primary Mantle Cell Lymphoma (Clinical Cancer Research) Wednesday October 1st 2014


157) Tumor Stromal Phenotypes Define VEGF Sensitivity--Response (Clinical Cancer Research) Wednesday October 1st 2014


158) Tumor Stromal Phenotypes Define VEGF Sensitivity--Letter (Clinical Cancer Research) Wednesday October 1st 2014


159) rs2735839 Is Associated with Prostate Cancer Aggressiveness (Clinical Cancer Research) Wednesday October 1st 2014


160) PIAS3 Expression in Mesothelioma (Clinical Cancer Research) Wednesday October 1st 2014


161) Phosphorylated STAT3 Expression in De Novo DLBCL (Clinical Cancer Research) Wednesday October 1st 2014


162) Role of TGF{beta} in Osteosarcoma (Clinical Cancer Research) Wednesday October 1st 2014


163) Wee1 and PARP1/2 Inhibition with Radiation (Clinical Cancer Research) Wednesday October 1st 2014


164) Anti-CCR4 Monoclonal Antibody for EBV-Associated T/NK-LPD (Clinical Cancer Research) Wednesday October 1st 2014


165) Association of PD-1 and Ligands with Response to Anti-PD-1 (Clinical Cancer Research) Wednesday October 1st 2014


166) The XAGE1 Antibody as a Biomarker for Lung Cancer (Clinical Cancer Research) Wednesday October 1st 2014


167) Phase II Trial of Cetuximab, Cisplatin, and Radiotherapy for LA-SCCHN (Clinical Cancer Research) Wednesday October 1st 2014


168) Phase I Study of CUDC-101 (Clinical Cancer Research) Wednesday October 1st 2014


169) Hypofractionated Radiotherapy, Temozolomide, and Bevacizumab for GBM (Clinical Cancer Research) Wednesday October 1st 2014


170) Therapeutic Vaccination to Treat EBV Malignancies (Clinical Cancer Research) Wednesday October 1st 2014


171) H3K27 Methylation in Cancer (Clinical Cancer Research) Wednesday October 1st 2014


172) Vemurafenib for Advanced Melanoma with BRAFV600E Mutation (Clinical Cancer Research) Wednesday October 1st 2014


173) New Insights: Oral, Chemotherapy-Free Management in APL (Clinical Cancer Research) Wednesday October 1st 2014


174) Selecting Patients for PD1/L1 Blockade Therapy (Clinical Cancer Research) Wednesday October 1st 2014


175) Reliable and Effective Diagnostics Keys: A Policy Statement from AACR (Clinical Cancer Research) Wednesday October 1st 2014


176) AACR Cancer Progress Report 2014: Transforming Lives Through Research (Clinical Cancer Research) Wednesday October 1st 2014


177) Correction: Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries (Clinical Cancer Research) Sunday September 14th 2014


178) Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer--Response (Clinical Cancer Research) Sunday September 14th 2014


179) Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer--Letter (Clinical Cancer Research) Sunday September 14th 2014


180) Excess MSS Colon Cancers in African Americans (Clinical Cancer Research) Sunday September 14th 2014


181) Brachyury in Prostate Cancer Progression and Prognosis (Clinical Cancer Research) Sunday September 14th 2014


182) BAP1 and KDM6A Bladder Cancer Mutations (Clinical Cancer Research) Sunday September 14th 2014


183) Molecular Features of Prostate Cancer in African Americans (Clinical Cancer Research) Sunday September 14th 2014


184) Smoking and Genomic Alterations in Lung Adenocarcinoma (Clinical Cancer Research) Sunday September 14th 2014


185) SPINK1 and Prostate Cancer (Clinical Cancer Research) Sunday September 14th 2014


186) Novel MSH6 Mutations and Temozolomide Resistance in Glioma (Clinical Cancer Research) Sunday September 14th 2014


187) Demethylating Drugs and Cancer Pain (Clinical Cancer Research) Sunday September 14th 2014


188) Mitochondrial Topoisomerase I Determines Doxorubicin Cardiotoxicity (Clinical Cancer Research) Sunday September 14th 2014


189) On-Target Apoptosis-Mediated Death by FK866 in CLL Cells (Clinical Cancer Research) Sunday September 14th 2014


190) BEZ235/Panobinostat Exhibits Potent Anti-NHL Activity (Clinical Cancer Research) Sunday September 14th 2014


191) Neoadjuvant Chemotherapy Reveals Specific Biomarkers (Clinical Cancer Research) Sunday September 14th 2014


192) Personalized Medicine in a Phase I Clinical Trials Program (Clinical Cancer Research) Sunday September 14th 2014


193) Functional Assay for PARP Inhibitor Treatment (Clinical Cancer Research) Sunday September 14th 2014


194) Imaging Reversal of MET-Mediated Resistance in NSCLC (Clinical Cancer Research) Sunday September 14th 2014


195) Clinical Significance of EpCAM mRNA-Positive CTCs in HCC (Clinical Cancer Research) Sunday September 14th 2014


196) miRNAs Predict Chemosensitivity in Lung Adenocarcinoma (Clinical Cancer Research) Sunday September 14th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

A Molecular Shuttle with Fluorescence Output

DuPont Names Spin-off ‘Chemours’

12/19/14 PHD comic: 'Holiday Plan'

Flexible White Organic LEDs Achieve Record Efficiencies

Here’s something we’re sure many of our readers will find...

Smartphone Microscope Sizes Up Single DNA Molecules

A Chemjobber holiday tradition

A neat ozone+UV paper pointed out by See Arr Oh

Officials scramble to respond to Bangladesh oil spill

Merck, Cubist, and Hospira: The Inside

Another Alzheimer's Antibody Goes Down

Podcast: The top science news stories of 2014

Less tasty shrimp, thanks to climate change

Science in the spotlight as New York state bans fracking

Clocking the hot gas gushing from the Milky Way's core


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()